Check out our most popular compounded medications! Get Started
Morphine Sulfate 75 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to manage various types of pain including chronic, cancer, postoperative, neuropathic, and arthritis pain. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 75 mg Slow Release Capsules are a potent, long-acting opioid analgesic designed to manage moderate to severe pain. This formulation is specifically engineered to provide a steady, consistent release of the active ingredient, Morphine Sulfate, over an extended period of time.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication over time, offering sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
However, this formulation is not recommended for patients with acute pain, as it may not provide immediate or adequate pain relief. It is also important for patients to be aware that Morphine Sulfate 75 mg Slow Release Capsules may cause side effects such as drowsiness, dizziness, and confusion. As such, patients should avoid driving or operating machinery while taking this medication.
Patients should also be aware of the potential for dependency with this medication. It is important to take Morphine Sulfate 75 mg Slow Release Capsules only as prescribed and not for a longer duration than recommended by a healthcare provider.
For healthcare providers, it is crucial to note that Morphine Sulfate 75 mg Slow Release Capsules may cause respiratory depression. Therefore, it should be used with caution in patients with respiratory conditions. Additionally, due to the potential for dependency, this medication should be prescribed for the shortest duration necessary to manage the patient's pain.
If you have any questions or concerns about Morphine Sulfate 75 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your medication needs.
Morphine Sulfate 75 mg Slow Release Capsules are a potent analgesic medication indicated for the management of moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the active ingredient over an extended period. This sustained release profile offers prolonged therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and extended release.
It is crucial to note that Morphine Sulfate 75 mg Slow Release Capsules should not be administered to patients with known hypersensitivity to morphine or other opioids. Additionally, they should not be used in patients with significant respiratory depression, acute or severe bronchial asthma, or other severe respiratory conditions. Caution is advised when using these capsules in patients with renal or hepatic impairment, as well as those with a history of substance abuse or mental illness.
Morphine Sulfate 75 mg Slow Release Capsules may interact with a variety of other medications, including but not limited to other opioids, sedatives, hypnotics, anxiolytics, muscle relaxants, antihistamines, and anticholinergics. Concomitant use of these medications may increase the risk of respiratory depression, hypotension, profound sedation, coma, and even death. Interactions may also occur with monoamine oxidase inhibitors (MAOIs) and drugs that affect serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs).
Furthermore, Morphine Sulfate 75 mg Slow Release Capsules may interact with alcohol and other drugs that cause drowsiness, such as antihistamines, antipsychotics, and muscle relaxants. Concomitant use of these substances may increase the risk of respiratory depression, hypotension, profound sedation, coma, and death.
If you have any questions or concerns about the interactions of Morphine Sulfate 75 mg Slow Release Capsules, please consult with a healthcare professional for further guidance.
Morphine Sulfate 75 mg Slow Release Capsules are a potent, extended-release opioid medication designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This slow-release mechanism provides a consistent level of pain relief, reduces the frequency of dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once a day, and should be consumed with food. It is crucial to adhere to the prescribed dosage and frequency as directed by your healthcare provider. Overdosing or underdosing, as well as taking the medication more frequently than advised, can lead to adverse effects or diminished efficacy.
Morphine Sulfate 75 mg Slow Release Capsules are versatile in their application, providing relief from chronic pain, cancer pain, post-operative pain, and pain associated with end-stage renal disease, sickle cell anemia, among other conditions. The medication functions by inhibiting pain signals from reaching the brain, thereby alleviating discomfort.
While effective, Morphine Sulfate 75 mg Slow Release Capsules may cause side effects such as nausea, constipation, dizziness, and drowsiness. It is essential to communicate any side effects experienced to your healthcare provider. Additionally, inform your doctor of any allergies or medical conditions that may be impacted by this medication.
If you have any queries regarding Morphine Sulfate 75 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you understand the workings of this medication and how it can assist in managing your pain.
Morphine Sulfate 75 mg Slow Release Capsules are a compounded formulation designed to provide sustained pain relief over an extended period of time. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the encapsulated medication. This slow release mechanism offers prolonged therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications requiring a controlled and extended release profile.
These capsules can be used to treat various types of pain, including musculoskeletal pain, fibromyalgia, and headaches. Additionally, Morphine Sulfate 75 mg Slow Release Capsules can be used to treat opioid-induced constipation and to reduce the severity of withdrawal symptoms in patients with opioid dependence.
However, caution should be exercised when using Morphine Sulfate 75 mg Slow Release Capsules in patients with renal or hepatic impairment, as well as in patients with a history of substance abuse. It is important to monitor patients for signs of respiratory depression, sedation, and constipation while they are taking this medication. If you have any questions or concerns about the use of Morphine Sulfate 75 mg Slow Release Capsules, please do not hesitate to reach out for further information.
Morphine Sulfate 75 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to offer sustained therapeutic effects, reduce dosing frequency, and improve patient compliance for medications requiring a controlled and prolonged release profile.
The slow release mechanism works by gradually releasing the encapsulated medication over an extended period of time. This allows for a steady level of medication in the body, offering sustained therapeutic effects.
The benefits of Morphine Sulfate 75 mg Slow Release Capsules include sustained therapeutic effects, reduced dosing frequency, and improved patient compliance due to its controlled and prolonged release profile.
The dosing frequency of Morphine Sulfate 75 mg Slow Release Capsules is typically less than that of regular medications due to its controlled-release formulation. However, the exact dosing schedule should be determined by your healthcare provider.
No, breaking or crushing the Morphine Sulfate 75 mg Slow Release Capsules can interfere with the controlled-release mechanism and may lead to a rapid release and absorption of a potentially fatal dose of morphine.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Side effects may include constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, abdominal pain. You should contact your healthcare provider if you experience any of these symptoms.
No, you should not drink alcohol while taking Morphine Sulfate 75 mg Slow Release Capsules as it can increase the risk of severe side effects.
You should consult your healthcare provider before taking Morphine Sulfate 75 mg Slow Release Capsules if you are pregnant or breastfeeding. This medication may have harmful effects on the fetus or a nursing infant.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
